A study in general practice of cephradine in respiratory tract infections.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002214:Capsules; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013535:Suspensions; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced
D002214:Capsules; D002511:Cephalosporins; D003510:Cyclohexanes; D013535:Suspensions